China has a drug that could help India battle deadly Nipah virus outbreak: study
AI Summary
Researchers at the Wuhan Institute of Virology in China have identified a potential treatment for the deadly Nipah virus, which has a high fatality rate and no approved cure. The study, released Monday, found that the oral antiviral drug VV116, originally developed for COVID-19, significantly improved survival rates in infected hamsters. Specifically, a dose of VV116 increased survival to 66.7% in golden hamsters and reduced the viral load in key organs affected by Nipah. The researchers suggest VV116 could be used preventatively for high-risk groups and as a readily available treatment option during Nipah outbreaks, such as the recent outbreak in West Bengal, India. This finding offers a promising avenue for managing and preventing the spread of the Nipah virus.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories